Changing diabetes in China
Download case: Blueprint for change: Changing diabetes in China (PDF)
Diabetes poses a growing social, educational and economic challenge for the Chinese society and the people and families affected by diabetes. The growth of diabetes is so serious that healthcare system will soon be struggling to cope.
Strengthening the healthcare system and establishing local stakeholder relations are key elements of Novo Nordisk’s long-term business strategy in China. Novo Nordisk continuously focuses on the long-term market building through physician training, patient education and local production. This strategy has created significant value for the Chinese society as well as for Novo Nordisk by reducing the personal and economic burden of diabetes and by increasing sales and enhancing Novo Nordisk reputation in China.
We have created value to Chinese society and Novo Nordisk by building local partnerships when addressing societal needs and at the same time increasing productivity in the value chain.